Business
CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder”
CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented
About this update from Natural Alternatives International, Inc.
[{"type":"text","content":"CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn® beta-alanine and patent-pending technology to increase beta-alanine bioavailability and absorption while effectively eliminating beta-alanine related paresthesia. The proprietary TriBsyn™ formulation successfully removes the common paresthesia sensation associated with efficacious dosages of beta-alanine, creating a brand-new opportunity to reach untapped consumers from older adults to vegetarians and vegans. Increased carnosine levels have been scientifically proven to provide a significant range of support for general wellness, including: Bolstering cognitive performance and improving mental fatigueIncreasing both muscle function and quality in older adultsSlowing the process of age-related health and mental decline In clinical trials, results showed the elimination of paresthesia and an increased pharmacokinetic efficiency, confirming TriBsyn’s™ enhanced delivery and exceptional bioavailability—improving the absorption of beta-alanine by more than four times compared to conventional beta-alanine. The increased efficiency allows for product formulations with significantly less beta-alanine, thereby improving formulation flexibility for various delivery systems. “After extensive research and trials, we are proud to announce TriBsyn™, which contains CarnoSyn®, the only beta-alanine approved by the FDA under NDI status,” said Aaron Starr, Vice President, CarnoSyn® Brands. “With the innovation of a paresthesia-free beta-alanine, TriBsyn™ sets a new standard in beta-alanine supplementation, ensuring that users can experience the full range of health benefits without the paresthesia or ‘tingling’ often experienced as a side effect. We eagerly anticipate the commercial launch of TriBsyn™ at our first industry event in September, at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy.” Ken Wolf, President of NAI shared, “TriBsyn’s™ launch will bolster our presence in a plethora of dietary supplement categories as well as fortified and medical foods. There is an evolving need and growing demand for healthy aging and wellness solutions—particularly for the aging population...